
ProShares UltraPro Short QQQ, Icon, Fastly, Direxion Daily TSLA Bull 2X Shares, Avadel Pharmaceuticals, American Airlines Group, and Cognex are the seven Mid Cap stocks to watch today, according to MarketBeat’s stock screener tool. Mid-cap stocks are shares of companies with medium market capitalizations—commonly defined as roughly $2 billion to $10 billion, though exact cutoffs vary by index and data provider. Investors view them as a middle ground between large-cap stability and small-cap growth, often offering a blend of growth potential with generally lower volatility than smaller companies. These companies had the highest dollar trading volume of any Mid Cap stocks within the last several days.
ProShares UltraPro Short QQQ (SQQQ)
ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.
Icon (ICLR)
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
Read Our Latest Research Report on ICLR
Fastly (FSLY)
Fastly, Inc. operates an edge cloud platform for processing, serving, and securing its customer's applications in the United States, the Asia Pacific, Europe, and internationally. The edge cloud is a category of Infrastructure as a Service that enables developers to build, secure, and deliver digital experiences at the edge of the internet.
Read Our Latest Research Report on FSLY
Direxion Daily TSLA Bull 2X Shares (TSLL)
Read Our Latest Research Report on TSLL
Avadel Pharmaceuticals (AVDL)
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017.
Read Our Latest Research Report on AVDL
American Airlines Group (AAL)
American Airlines Group Inc., through its subsidiaries, operates as a network air carrier. The company provides scheduled air transportation services for passengers and cargo through its hubs in Charlotte, Chicago, Dallas/Fort Worth, Los Angeles, Miami, New York, Philadelphia, Phoenix, and Washington, D.C., as well as through partner gateways in London, Doha, Madrid, Seattle/Tacoma, Sydney, and Tokyo.
Read Our Latest Research Report on AAL
Cognex (CGNX)
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Read Our Latest Research Report on CGNX
Further Reading
- MarketBeat’s Top Five Stocks to Own in February 2026
- Why Robinhood’s Nearly 50% Slide Is a Buy-the-Dip Opportunity
- Is Albemarle Setting Up for a Lithium-Fueled Rebound?
- 4 Reasons Fortinet Could Be at a Buyable Bottom
- A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH
- Exelixis Reports Solid Earnings—Are New Highs Back on the Table?
